Zions Bancorporation N.A. Has $4.16 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Zions Bancorporation N.A. boosted its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 19.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,413 shares of the medical equipment provider's stock after purchasing an additional 5,095 shares during the quarter. Zions Bancorporation N.A. owned about 0.09% of Integer worth $4,163,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mather Group LLC. raised its stake in shares of Integer by 304.3% during the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 143 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of Integer during the 4th quarter worth about $27,000. R Squared Ltd acquired a new stake in shares of Integer in the 4th quarter worth approximately $44,000. Versant Capital Management Inc increased its stake in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 183 shares during the period. Finally, Principal Securities Inc. lifted its position in Integer by 31.2% in the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after purchasing an additional 152 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Stock Down 0.3 %

Shares of ITGR stock traded down $0.41 on Friday, reaching $117.09. 310,618 shares of the company's stock traded hands, compared to its average volume of 325,140. The business's 50 day moving average price is $130.47 and its two-hundred day moving average price is $132.03. The company has a market capitalization of $3.94 billion, a P/E ratio of 34.85, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 12-month low of $107.11 and a 12-month high of $146.36.

Remove Ads

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The business had revenue of $449.50 million for the quarter, compared to analysts' expectations of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. On average, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of several research analyst reports. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, February 21st. Citigroup boosted their target price on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a report on Wednesday, December 11th. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. KeyCorp lifted their target price on Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Finally, Wells Fargo & Company reiterated an "overweight" rating and issued a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $148.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.